Leila Alland
Board Member
Abeona Therapeutics Inc. (ABEO)Equibles does not estimate personal net worth.
Get an email with a short summary when Abeona Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ABEO alertsAbout Leila Alland
Leila Alland is recorded as Board Member at Abeona Therapeutics Inc. (ABEO). The newest filing on record that lists Leila Alland as Board Member at Abeona Therapeutics Inc. (ABEO) is dated April 27, 2026. Abeona Therapeutics Inc. reported in an 8-K filed April 24, 2024 that Leila Alland was appointed Class 2 director, effective April 24, 2024. PMV Pharmaceuticals, Inc. reported in an 8-K filed January 5, 2024 that Leila Alland resigned as Chief Medical Officer (“CMO”), effective January 5, 2024. The proxy statement of PMV Pharmaceuticals, Inc. reports total compensation of $1,400,292 for Leila Alland in fiscal 2021, including a base salary of $456,083. Disclosed compensation is on record for 2 fiscal years. Abeona Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Abeona Therapeutics Inc. includes Michael Amoroso (CEO, Chairman, COO and Board Member), Vishwas Seshadri (CEO and Board Member), Brian J.G. Pereira (Chairman and Board Member) and 7 others.
“Leila Alland and Vishwas Seshadri were elected to serve as Class 2 directors of the Company until the 2027 annual meeting of stockholders and until their successors are elected and qualified.”
“Also on January 5, 2024, the Company announced that Leila Alland, M.D., the Company’s Chief Medical Officer (“CMO”), will transition from her role as CMO, effective on January 5, 2024.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
PMV Pharmaceuticals, Inc. (PMVP)
Proxy statement
Start not stated–2024-01-05
Company network
Leadership on record at Abeona Therapeutics Inc.
- Michael Amoroso CEO, Chairman, COO, Board Member
- Vishwas Seshadri CEO, Board Member
- Brian J.G. Pereira Chairman, Board Member
- Edward Carr CFO
- Joseph Vazzano CFO
- Brendan O’Malley General Counsel
- Bernhardt G. Zeiher Board Member
- Christine Berni Silverstein Board Member
- Christine Silverstein Board Member
- Donald A. Wuchterl Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | PMV Pharmaceuticals, Inc. (PMVP) | Chief Medical Officer | $456,083 | $1,400,292 |
| 2020 | PMV Pharmaceuticals, Inc. (PMVP) | Chief Medical Officer | $445,000 | $1,674,649 |